Pfizer's patient push

Pfizer Inc. has concluded that patient-focused drug development must be an iterative approach that starts early and lasts throughout the R&D process. The challenge for any company is systematizing the approach and figuring out how to turn individual stories into actionable information.

Roslyn Schneider's mandate is to do exactly that. Schneider, an M.D. who joined Pfizer in 2006, this year became senior director of medical strategy, reporting directly to EVP and CMO Freda Lewis-Hall. ...